What Researchers Did
Researchers conducted a pilot randomized controlled trial with 17 patients to characterize early thermal burns and assess the effects of hyperbaric oxygen treatment (HBOT) administered within 24-48 hours post-injury.
What They Found
White blood cell counts and several serum inflammatory markers (IL-1β, IL-4, IL-6, IL-10, interferon-γ) were significantly elevated 24 hours post-burn in patients with less than 40% total body surface area burns. However, early hyperbaric oxygen treatment showed no significant effect on burn depth, inflammatory markers, or the incidence of positive bacterial cultures (2 HBOT patients vs. 4 control patients).
What This Means for Canadian Patients
This pilot study suggests that early hyperbaric oxygen treatment may not significantly improve outcomes for Canadian patients with early thermal burns. Patients should continue to receive standard burn care as current evidence does not support the routine use of HBOT for this type of injury.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian researchers or participants.
Study Limitations
A significant limitation of this study was the considerably smaller patient recruitment (17 subjects) than originally planned, making it a small pilot study.